Oncology Medical News about rectal cancer;Topoisomerase I expression;rneoadjuvant irinotecan-based chemoradiation

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer
Anti-Cancer Drugs, 07/02/09

Post S et al. - In a study to assess whether expression of topoisomerase I (Topo I) and thymidylate synthase (TS) helps predict treatment response in pts undergoing irinotecan and capecitabine-based chemoradiation, it was reported that Topo I expression in rectal tumour mucosa might serve as a predictor of response to neoadjuvant irinotecan-based chemoradiation, and might be a factor contributing to development of individualized treatment.

Methods

Pts with rectal cancer (cT3/4Nx or Tx/N+) received neoadjuvant chemoradiotherapy within clinical studies with irinotecan and capecitabine.
Samples of normal and tumour tissues were collected before start of treatment and during surgical resection.
Topo I and TS were measured using real-time PCR.

Results

38 pts were analysed, 18 of them were responders.
Biopsies of untreated tumour tissue of responding pts showed a significant higher expression of Topo I vs nonresponding pts.
Normal tissue did not show this difference.
During chemoradiation, Topo I expression in tumour tissue of responders decreased significantly.
TS did not show any differences between responders and nonresponders before treatment, but a significant decrease in the tumour tissue of responders was noted at the end of treatment.

<< Previous
Prevention of pancreatic cancer by the beta-blocker propranolol

Next >>
Type I collagen inhibits differentiation and promotes a stem...